Marie‐Claire Vandermeers‐Piret

Author

Also Known As

M C Vandermeers-Piret, MARIE-CLAIRE VANDERMEERSPIRET, MARIE‐CLAIRE VANDERMEERS‐PIRET, Marie-Claire Vandermeers-Piret, Marie-Claire Vandermeers-piret, Marie‐Claire VANDERMEERS‐PIRET, Marie‐Claire Vandermeers‐Piret

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Université Libre de Bruxelles KU Leuven University of Shizuoka Centre Hospitalier Universitaire de Saint-Pierre Musashigaoka College

About

Marie‐Claire Vandermeers‐Piret is an author at Université Libre de Bruxelles specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	22	901
2	Biochemistry	11	13	371
3	Natural Sciences	6	6	210
4	Social Sciences	2	2	47
5	Allergy	2	2	93

Marie‐Claire Vandermeers‐Piret

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Structural requirements for the occupancy of pituitary adenylate‐cyclase‐activating‐peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB‐OK‐1 cell membranes Patrick Robberecht, Philippe Gourlet, Philippe De Neef, European Journal of Biochemistry	1992	220
The Long-Acting Vasoactive Intestinal Polypeptide Agonist RO 25-1553 Is Highly Selective of the VIP 2 Receptor Subclass Philippe Gourlet, Pascale Vertongen, André Vandermeers, Peptides Receptor SubclassSignal TransductionGastrointestinal Peptide HormoneFunctional SelectivityMedicine	1997	151
Properties and distribution of receptors for pituitary adenylate cyclase activating peptide (PACAP) in rat brain and spinal cord Annick Cauvin, Patrick Robberecht, Philippe De Neef, Regulatory Peptides Pituitary GlandMedicinePhysiologyReceptor (Biochemistry)Neuropeptide Receptor	1991	93
Fragments of pituitary adenylate cyclase activating polypeptide discriminate between type I and II recombinant receptors Philippe Gourlet, André Vandermeers, Marie‐Claire Vandermeers‐Piret, European Journal of Pharmacology Molecular PhysiologySignal TransductionPolypeptide DiscriminatePituitary GlandMedicine	1995	78
The two forms of the pituitary adenylate cyclase activating polypeptide (PACAP (1–27) and PACAP (1–38)) interact with distinct receptors on rat pancreatic AR 4‐2J cell membranes Patrick Robberecht, M.C. Woussen-Colle, Philippe De Neef, FEBS Letters	1991	64
Evidence that helodermin, a newly extracted peptide from Gila monster venom, is a member of the secretin/VIP/PHI family of peptides with an original pattern of biological properties Patrick Robberecht, Magalì Waelbroeck, Jean‐Paul Dehaye, FEBS Letters	1984	59
Structural requirements for the binding of the pituitary adenylate‐cyclase‐activating peptide to receptors and adenylate‐cyclase activation in pancreatic and neuronal membranes Philippe Gourlet, M.C. Woussen-Colle, Patrick Robberecht, European Journal of Biochemistry	1991	59
Chemical, immunological and biological properties of peptides like vasoactive‐intestinal‐peptide and peptide‐histidine‐isoleucinamide extracted from the venom of two lizards (<i>Heloderma horridum and Heloderma suspectum</i>) Andé VANDERMEEERS, Philippe Gourlet, Marie‐Claire Vandermeers‐Piret, European Journal of Biochemistry ToxinologyImmunologyBiological PropertiesPeptide SciencePeptide Therapeutics	1987	57
Antagonistic properties are shifted back to agonistic properties by further N‐terminal shortening of pituitary adenylate‐cyclase‐activating peptides in human neuroblastoma NB‐OK‐1 cell membranes André Vandermeers, Stéphane VANDENBORRE, Xue Hou, European Journal of Biochemistry	1992	53
Immunoreactive helodermin-like peptides in rat: A new class of mammalian neuropeptides related to secretin and VIP Patrick Robberecht, Jacques De Graef, Marie-Claire Woussen, Biochemical and Biophysical Research Communications NeuropeptidesMammalian NeuropeptidesMedicinePhysiologyPharmacology	1985	45

Page 1